These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 28330603)
1. DHX32 Promotes Angiogenesis in Colorectal Cancer Through Augmenting β-catenin Signaling to Induce Expression of VEGFA. Lin H; Fang Z; Su Y; Li P; Wang J; Liao H; Hu Q; Ye C; Fang Y; Luo Q; Lin Z; Pan C; Wang F; Zhang ZY EBioMedicine; 2017 Apr; 18():62-72. PubMed ID: 28330603 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer. Lin H; Liu W; Fang Z; Liang X; Li J; Bai Y; Lin L; You H; Pei Y; Wang F; Zhang ZY Sci Rep; 2015 Mar; 5():9247. PubMed ID: 25782664 [TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer. Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978 [TBL] [Abstract][Full Text] [Related]
4. miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer. Fang Y; Sun B; Wang J; Wang Y Gene; 2019 May; 699():37-42. PubMed ID: 30851425 [TBL] [Abstract][Full Text] [Related]
5. FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA. Wang S; Xiao Z; Hong Z; Jiao H; Zhu S; Zhao Y; Bi J; Qiu J; Zhang D; Yan J; Zhang L; Huang C; Li T; Liang L; Liao W; Ye Y; Ding Y Cancer Lett; 2018 Dec; 439():78-90. PubMed ID: 30253191 [TBL] [Abstract][Full Text] [Related]
6. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
7. DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway. Hu X; Yuan G; Li Q; Huang J; Cheng X; Chen J Ann Med; 2021 Dec; 53(1):437-447. PubMed ID: 33729094 [TBL] [Abstract][Full Text] [Related]
8. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression. He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604 [TBL] [Abstract][Full Text] [Related]
9. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232 [TBL] [Abstract][Full Text] [Related]
10. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression. Wang R; Ma Y; Zhan S; Zhang G; Cao L; Zhang X; Shi T; Chen W Cell Death Dis; 2020 Jan; 11(1):55. PubMed ID: 31974361 [TBL] [Abstract][Full Text] [Related]
11. Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4. Yang L; Hu S; Tan J; Zhang X; Yuan W; Wang Q; Xu L; Liu J; Liu Z; Jia Y; Huang X Oncotarget; 2016 Sep; 7(38):61562-61574. PubMed ID: 27528036 [TBL] [Abstract][Full Text] [Related]
12. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis. Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032 [TBL] [Abstract][Full Text] [Related]
13. Sporamin suppresses growth of xenografted colorectal carcinoma in athymic BALB/c mice by inhibiting liver β-catenin and vascular endothelial growth factor expression. Yang C; Zhang JJ; Zhang XP; Xiao R; Li PG World J Gastroenterol; 2019 Jul; 25(25):3196-3206. PubMed ID: 31333311 [TBL] [Abstract][Full Text] [Related]
14. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression. Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398 [TBL] [Abstract][Full Text] [Related]
15. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation. Zhang Y; Wang S; Kang W; Liu C; Dong Y; Ren F; Wang Y; Zhang J; Wang G; To KF; Zhang X; Sung JJ; Chang Z; Yu J Oncogene; 2018 Jun; 37(26):3485-3500. PubMed ID: 29563608 [TBL] [Abstract][Full Text] [Related]
16. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer. Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979 [TBL] [Abstract][Full Text] [Related]
17. CTEN Inhibits Tumor Angiogenesis and Growth by Targeting VEGFA Through Down-Regulation of β-Catenin in Breast Cancer. Lu X; Zhou B; Cao M; Shao Q; Pan Y; Zhao T Technol Cancer Res Treat; 2021; 20():15330338211045506. PubMed ID: 34817293 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer. Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187 [TBL] [Abstract][Full Text] [Related]
19. MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis. Zhou Q; Zhu Y; Wei X; Zhou J; Chang L; Sui H; Han Y; Piao D; Sha R; Bai Y Cell Death Dis; 2016 Oct; 7(10):e2413. PubMed ID: 27735951 [TBL] [Abstract][Full Text] [Related]
20. ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB. Cheng X; Jin Z; Ji X; Shen X; Feng H; Morgenlander W; Ou B; Wu H; Gao H; Ye F; Zhang Y; Peng Y; Liang J; Jiang Y; Zhang T; Qiu W; Lu X; Zhao R Int J Cancer; 2019 Jul; 145(1):179-191. PubMed ID: 30650178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]